February 10, 2021

PGV adopted for a NEDO's program, "2020 Innovation Promotion Project for Accelerating AI Chip Development."

NEDO (New Energy and Industrial Technology Development Organization) adopted PGV’s proposal for "2020 Innovation Promotion Project for Accelerating AI Chip Development.”  In this project, PGV plans to improve the productivity of the AI development environments by developing "pre-processing chips," equipped with data pre-processing technology, and "brain wave AI development tools." 

January 20, 2021

PGV introduced in a Nikkei Business Daily's article about Osaka University.

A Nikkei Business Daily's article covered industry-academia collaboration and commercialization by the Institute of Scientific and Industrial Research, Osaka University.   The article introduced PGV business and an interview with PGV founder, Professor Sekitani, Osaka University.

December 1, 2020

PGV concludes a joint research agreement with Osaka University.

PGV and  Osaka University agree to jointly research and develop diagnostic technology for neurological diseases such as dementia using PGV patch-type EEG.

September 2, 2020

Monthly Journal of Pharmaceutical Business (2020.09.01, Iyaku Keizai) carries an interview article with PGV CEO.

August 20, 2020

PGV obtains License Certificate for Selling and Leasing Specially-Controlled Medical Device on August 17, 2020.

August 19, 2020

PGV obtains a medical device certification for “Patch-Type EEG HARU-1.”

July 14, 2020

PGV raises 150 million yen through third-party allotment of new shares to OSAKA University Venture Capital Co., Ltd.

April 13, 2020

Recruiting information updated; an opening for a brain-wave data analyst position.

April 1, 2020

2020.4.1 Nikkei Business Daily covers PGV’s business leveraging its patch-type EEG sensor, jointly developed with Nippon Mektron.

March 13, 2020

PGV obtains permits for “Marketing of Class II Medical Devices” and “Manufacturing of Medical Devices.”